Canada Early Toxicity Testing Market Set to Reach USD 124.39 Billion by 2030

According to Next Move Strategy Consulting, the Canada Early Toxicity Testing Market is predicted to reach USD 124.39 million with a CAGR of 9.15% till 2030.

With rise in biotechnology and pharmaceutical industries in Canada, there is an increase in drug research and development activities. This is leading to a higher demand for early toxicity testing services to support development of new vaccines and medication products.

The rise in initiatives of governments for development of healthcare and pharmaceutical industry in the country further propels growth of the market.

Request For FREE Sample: https://www.nextmsc.com/canada-early-toxicity-testing-market/request-sample